Clinical Trials
3 trialsNCT06892223 2025-03-24
Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation
Istituto Clinico Humanitas
Phase 2 Recruiting
NCT02557516 2019-12-17
Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL
Innate Pharma
Phase 1/2 Terminated
NCT02921685 2018-09-19
PIRAT
Institut Paoli-Calmettes
Phase 1 Unknown